Brinton Pharma to launch Molnupiravir soon

05 January 2022 | News

Each pack will have 40 capsule of 200 mg strength

Image Credit: Shutterstock

Image Credit: Shutterstock

Brinton Pharmaceutical will launch Molnupiravir with the brand name ‘Molviton’ a promising drug for SARS-Cov-2 across the domestic market. The drug will be available in 200 mg capsule form as patient compliance. Each pack will have 40 capsules as the general recommended dosage is 800 mg twice/day for 5 days. Going forward the company is also working on 400 mg and 800 mg capsules. It will be available at all leading pharmacies and Covid treatment centres across the country.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account